首页 › 基金 › BRAIDWELL LP › MAZE

BRAIDWELL LP 对 MAZE 的持仓历史

MAZE THERAPEUTICS INC COM · 医疗保健

BRAIDWELL LP 在 Q2 2026 的 13F 申报中披露持有 MAZE(MAZE THERAPEUTICS INC COM)1,140,040 股,市值约 US$34.0M,约占其申报组合的 1.34%,在其申报持仓中市值排名第 27 位。 BRAIDWELL LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)1.14M 股
申报持仓市值$34.02M
组合权重1.34%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

BRAIDWELL LP 对 MAZE 的持仓演变

BRAIDWELL LP 于 Q2 2026 首次披露 MAZE 持仓:1,140,040 股(约 US$34.0M)。

逐季持仓明细

季度股数金额变化
Q2 2026 1.14M $34.02M 新进

关于 MAZE 与 13F 数据

MAZE(MAZE THERAPEUTICS INC COM)属于医疗保健行业。我们追踪的基金中还有 74 只申报持有 MAZE,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MAZE 的基金

查看 MAZE 的全部基金持有人 →

常见问题

How long has BRAIDWELL LP held MAZE?

BRAIDWELL LP has disclosed MAZE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is BRAIDWELL LP's current position in MAZE?

As of Q2 2026, BRAIDWELL LP holds 1.14M shares of MAZE (MAZE THERAPEUTICS INC COM), valued at $34.02M, representing 1.34% of its reported portfolio and ranking #27.

Has BRAIDWELL LP been buying or selling MAZE?

In the latest 13F filing (Q2 2026), BRAIDWELL LP newly opened its position in MAZE.

Which other funds hold MAZE?

Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.